Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis

NCT01490411 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinoconjunctivitis

Interventions

DRUG: Placebo
BIOLOGICAL: rBet v1-FV
BIOLOGICAL: rBet v1-FV
BIOLOGICAL: rBet v1-FV
BIOLOGICAL: rBet v1-FV

Sponsor

Allergopharma GmbH & Co. KG